Analysts have provided the following ratings for Crinetics Pharmaceuticals (NASDAQ:CRNX) within the last quarter:
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 1 | 3 | 0 | 0 | 0 |
Last 30D | 0 | 1 | 0 | 0 | 0 |
1M Ago | 0 | 1 | 0 | 0 | 0 |
2M Ago | 1 | 1 | 0 | 0 | 0 |
3M Ago | 0 | 0 | 0 | 0 | 0 |
According to 4 analyst offering 12-month price targets in the last 3 months, Crinetics Pharmaceuticals has an average price target of $45.0 with a high of $56.00 and a low of $35.00.
Support authors and subscribe to content
This is premium stuff. Subscribe to read the entire article.
Login if you have purchased